Alan N Charney MD

Physician

111 Prospect StWestfield, NJ 07090
Phone+1 973-975-7910

Dr. Charney is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Charney's full profile Already have an account?

Education & Training

SUNY Upstate Medical UniversityResidency, Gastroenterology, 2021 - 2027
Yale-New Haven Medical CenterFellowship, Nephrology, 1971 - 1972
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1969 - 1971
Lincoln Medical and Mental Health CenterInternship, Transitional Year, 1968 - 1969
Albert Einstein College of MedicineClass of 1968

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1969 - 2027

Publications & Presentations

PubMed

95 citations
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.
Hong Zhang, Dana V Rizk, Vlado Perkovic, Bart Maes, Naoki Kashihara
Kidney International. 2024-01-01
16 citations
Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome.
David Kavanagh, Larry A Greenbaum, Arvind Bagga, Rajeshri G Karki, Chien-Wei Chen
Kidney International Reports. 2023-07-01
48 citations
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study.
Dana V Rizk, Brad H Rovin, Hong Zhang, Naoki Kashihara, Bart Maes
Kidney International Reports. 2023-05-01